
Am J Psychiatry 1988; 145:1110-1114
Copyright © 1988 by American Psychiatric Association
S-adenosylmethionine treatment of depression: a controlled clinical trial
KM Bell, L Plon, WE Bunney Jr and SG Potkin
University of California, Irvine Medical Center, Orange 92668.
The antidepressant properties of S-adenosylmethionine, an endogenous methyl
donor, were studied in inpatients who met the DSM-III criteria for major
depression. Nine patients given intravenous S- adenosylmethionine and nine
given low oral doses of imipramine were compared in a double-blind design
for 14 days. The S-adenosylmethionine produced superior results by the end
of the first week of treatment. By the end of the second week, 66% of the
S-adenosylmethionine patients had a clinically significant improvement in
depressive symptoms, compared to 22% of the imipramine patients. Side
effects appeared to be fewer with S-adenosylmethionine than with imipramine
during the last 5 days of the study.
This article has been cited by other articles:

|
 |

|
 |
 
M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu
The Homocysteine Hypothesis of Depression
Am J Psychiatry,
June 1, 2007;
164(6):
861 - 867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mischoulon and M. Fava
Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence
Am. J. Clinical Nutrition,
November 1, 2002;
76
(5):
1158S - 1161S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Saletu, P. Anderer, C. Di Padova, A. Assandri, and G. M. Saletu-Zyhlarz
Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography
Am. J. Clinical Nutrition,
November 1, 2002;
76
(5):
1162S - 1171S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Delle Chiaie, P. Pancheri, and P. Scapicchio
Efficacy and tolerability of oral and intramuscular S-adenosyl- L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies
Am. J. Clinical Nutrition,
November 1, 2002;
76
(5):
1172S - 1176S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Calvaresi and J. Bryan
B Vitamins, Cognition, and Aging: A Review
J. Gerontol. B. Psychol. Sci. Soc. Sci.,
November 1, 2001;
56(6):
P327 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D Fernstrom
Can nutrient supplements modify brain function?
Am. J. Clinical Nutrition,
June 1, 2000;
71(6):
1669S - 1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Xie, S.-L. Ho, and D. Ramsden
Characterization and Implications of Estrogenic Down-Regulation of Human Catechol-O-Methyltransferase Gene Transcription
Mol. Pharmacol.,
July 1, 1999;
56(1):
31 - 38.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. R. Bell, J. S. Edman, J. Miller, N. Hebben, R. T. Linn, D. Ray, and H. L. Kayne
Relationship of Normal Serum Vitamin B12 and Folate Levels to Cognitive Test Performance in Subtypes of Geriatric Major Depression
J Geriatr Psychiatry Neurol,
April 1, 1990;
3(2):
98 - 105.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1988
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|